β-blockers are associated with a reduction in COPD exacerbations

BACKGROUND: While some retrospective studies have suggested that β-blocker use in patients with chronic obstructive pulmonary disease (COPD) is associated with a reduction in the frequency of acute exacerbations and lower mortality, there is concern that their use in patients with severe COPD on hom...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorax
Main Authors: Bhatt, Surya P., Wells, James M., Kinney, Gregory L., Washko, George R., Budoff, Matthew, Kim, Young-il, Bailey, William C., Nath, Hrudaya, Hokanson, John E., Silverman, Edwin K., Crapo, James, Dransfield, Mark T.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5154678/
https://ncbi.nlm.nih.gov/pubmed/26283710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thoraxjnl-2015-207251
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados